Skip Navigation LinksHome > Webinars
Rating Webinars
0.0

BIA Member Webinar: MRC Molecular Pathology Nodes: People, Proximity and Path [0]
Course sponsor: The BioIndustry Association
The MRC and EPSRC have supported six molecular pathology nodes led by the universities of Edinburgh, Glasgow, Leicester, Manchester, Newcastle and Nottingham. Each node brings researchers, clinicians and industry together to develop molecular diagnostic tools, to enable stratification, in disease areas such as cancer, respiratory diseases, digestive disease, infections, rheumatoid arthritis, psoriasis and lupus. The six nodes are collaborating with 20 industrial partners, including leading diagnostic and instrumentation companies and innovative technology and data SMEs. Dr Newland will provide a brief overview of the six Nodes and the background to why they were set up by the MRC. We will then hear from the coordinators of two of these Nodes; Professor Brightling will present the Breathomics Pathology node (EMBER) and Dr Oien will present the Glasgow Pathology Node (GMP), both discussing what their particular Node is focussing on and what diagnostics they are developing.   Contact hours - 0.75
June 07, 2018; 04:00 PM, UTC +01:00
Up Arrow
0.0

Breast Cancer Pathology Reports & Contrast Ultrasound [0]
Course sponsor: Advanced Health Education Center, Ltd.
At the conclusion of the course the participant should be able to: 1. Discuss appropriate information discussed with patient 2. Understand the job of a breast pathologist 3. Understand how to report information from the patient 4. Identify the differences between radical scars and malignancy 5. Name the categories of calcifications 6. List steps of breast cancer staging 7. Understand the basics of contrast ultrasound.   Contact hours - 1.00
July 02, 2018; 12:00 PM, UTC -05:00
Up Arrow
0.0

Breast Cancer Pathology Reports & Contrast Ultrasound [0]
Course sponsor: Advanced Health Education Center, Ltd.
At the conclusion of the course the participant should be able to: 1. Discuss appropriate information discussed with patient 2. Understand the job of a breast pathologist 3. Understand how to report information from the patient 4. Identify the differences between radical scars and malignancy 5. Name the categories of calcifications 6. List steps of breast cancer staging 7. Understand the basics of contrast ultrasound Course Topics: Mammography Pathology Reports Information Discussed with the Patien A Breast Pathologist’s Job Report Information Hormone Status for the Breast Guess the Lesion Game Solid Lesions Radical Scar vs. Malignancy Categories of Calcifications Contrast Breast Ultrasound Breast Cancer Staging Basics and Principles of Contrast Ultrasound Efficacy of Real Time Contrast Ultrasound   Contact hours - 2.50
December 02, 2018; 10:00 AM, UTC -06:00
Up Arrow
0.0

Cervical Malignancies and Potential Pap Pitfalls [Cme, Sam, Cmle]
Course sponsor: American Society of Cytopathology (ASC)
Due to successful cervical screening programs, malignant Pap tests are decreasing in number in most laboratories. This leads to fewer opportunities for cytotechnologists and cytopathologists to view cervical malignancies on Pap tests and develop familiarity with cytomorphologic features of malignancy. As the recommended interval between Pap tests increases, prompt recognition of these features will become even more essential in providing quality patient care. This webinar reviews our experience with numerous Paps from confirmed cervical malignancies (squamous and glandular) with pertinent clinical, HPV, and histopathologic data. Key tips and challenging cases will also be discussed.   Contact hours - 1.00
August 28, 2018; 03:00 PM, UTC -04:00
Up Arrow
0.0

Cryostaining Muscle Tissue for Enzymes [0]
Course sponsor: National Society for Histotechnology (NSH)
This webinar will discuss the process of collection, preparation, cryosectioning and staining muscle tissue for enzymes. It will discuss the background of why fresh muscle is required, and will also touch on pathological indicators give the histologist a more in depth understanding.   Contact hours - 1.00
September 19, 2018; 12:00 PM, UTC -04:00
Up Arrow
0.0

Discrepancies and Errors in Cytology Cases with Emphasis on Recognizing the Sources of Errors [Cme, Sam, Cmle]
Course sponsor: American Society of Cytopathology (ASC)
This webinar with provide a practical review of a few litigation or mis- diagnosed cytology cases that were identified after correlation with the surgical outcomes. Using case-based presentation; this webinar will present challenging gynecological and non-gynecologic cases. The goal of this webinar will be to increase the skills of cytopatholgists and surgical pathologists to recognize potential diagnostic pitfalls in diagnosis. Erroneous diagnosis can cause delay in diagnosis or sometimes overtreatment and unnecessary surgeries. Our goal is to learn from these mistakes and improve our abilities to prevent future ones. Solutions for handling similar cases with the listing of differential diagnosis, clear cytopathology reporting and finally assessment of surgical outcomes will be provided.   Contact hours - 1.00
December 11, 2018; 03:00 PM, UTC -05:00
Up Arrow
0.0

Interpretation of FNA Material of Lymph Nodes Involved by Lymphoproliferative Disorders [Cme, Sam, Cmle]
Course sponsor: American Society of Cytopathology (ASC)
Selected common and challenging lymphoproliferative disorders involving lymph nodes and encountered in a current cytopathology practice, will be reviewed in this session. Common pitfalls in the diagnostic assessment of these neoplasms will be reviewed integrating clinical presentation, imaging findings, and ancillary testing. The role of the cytopathologist and cytotechnologist in the multidisciplinary team will also be highlighted.   Contact hours - 1.00
October 23, 2018; 03:00 PM, UTC -04:00
Up Arrow
0.0

Molecular Diagnostics in Cytopathology: Opportunities, Limitations and Pitfalls [Cme, Sam, Cmle]
Course sponsor: American Society of Cytopathology (ASC)
Molecular diagnostics is increasingly being utilized to help guide targeted therapy in solid organ tumors. Cytopathologists are at the forefront of triaging specimens during rapid on-site evaluation and selecting specimens for ancillary testing. Therefore, it is imperative that practicing cytopathologists stay abreast of up-to-date diagnostic and prognostic ancillary tests utilizing limited cytologic material. This presentation will focus on cytologic substrates for ancillary studies, along with the advantages and disadvantages of each, to help the participants triage and devise optimal strategies for ancillary testing in their own practices.   Contact hours - 1.00
September 25, 2018; 03:00 PM, UTC -04:00
Up Arrow
0.0

Non-Small Cell Carcinoma Biomarker Testing: The Cytopathologist’s Viewpoint [0]
Course sponsor: American Society of Cytopathology (ASC)
Many decisions about treatment in lung cancer are made on the basis of specific molecular and protein expression. This webinar is designed to give practicing cytopathologists a general introduction to the targeted therapy testing required for non-small cell lung carcinomas as well as a strategy to maximize limited specimens for several rounds of testing. In this course we will review the pre-analytical factors in specimen collection, from EBUS to biopsy to resection, and consider how specimen collection can affect testing. Finally, we will discuss several case examples alongside the targeted therapy testing followup and consider how to integrate targeted therapy testing into the cytopathologist’s immediate assessment workflow.   Contact hours - 1.00
November 27, 2018; 03:00 PM, UTC -05:00
Up Arrow
0.0

Pathology Driving Decisions--What is your diagnosis and what are your options? [0]
Course sponsor: GoToWebinar
Your bladder cancer pathology report is essential to determining the stage and grade of your tumor. Your healthcare team uses that information to determine the best treatment options for your particular disease. Once they know the details of your tumor, what is the Standard of Care for your bladder cancer? 1. Brief overview of what is learned in pathology report & how that drives treatment options 2. T1-T4, What does that mean? 3.NMIBC Standard of Care-- what are your options? 4. MIBC Standard of Care-- what are your options? 5. Metastatic/Advanced Bladder Cancer Standard of Care-- what are your options? 6. Q&A from participants   Contact hours - 1.00
May 07, 2018; 06:00 PM, UTC -04:00
Up Arrow